Calliditas Therapeutics AB (publ) (CALT)
NASDAQ: CALT · IEX Real-Time Price · USD
19.47
+0.27 (1.41%)
At close: Apr 26, 2024, 1:40 PM
19.34
-0.13 (-0.67%)
After-hours: Apr 26, 2024, 4:00 PM EDT

CALT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023202220212020
Market Capitalization
523767502618778
Market Cap Growth
-52.65%-18.74%-20.55%-
Enterprise Value
523766452536657
PE Ratio
-16.58-16.58-12.67-11.12-14.72
PS Ratio
4.386.416.5124.267301.43
PB Ratio
17.1123.096.825.525.27
P/FCF Ratio
-17.28-17.28-16.65-11.89-20.64
P/OCF Ratio
-17.79-17.79-16.78-12.06-20.64
EV/Sales Ratio
4.376.405.8621.036162.50
EV/EBITDA Ratio
-22.54-22.54-12.66-9.74-14.32
EV/EBIT Ratio
-22.54-22.54-12.66-9.74-14.32
EV/FCF Ratio
-17.26-17.26-14.99-10.30-17.42
Debt / Equity Ratio
2.892.890.950.210.00
Debt / EBITDA Ratio
-2.82-2.82-1.96-0.430.00
Debt / FCF Ratio
-2.16-2.16-2.32-0.460.00
Quick Ratio
2.842.844.087.059.43
Current Ratio
3.133.134.347.489.82
Asset Turnover
0.630.630.470.160.00
Interest Coverage
-3.00-3.00-9.87-53.48-6.60
Return on Equity (ROE)
-84.70%-84.70%-46.50%-45.10%-36.60%
Return on Assets (ROA)
-24.50%-24.50%-24.20%-34.20%-33.50%
Return on Capital (ROIC)
-28.67%-28.67%-28.22%-42.94%-31.35%
Earnings Yield
-8.83%-6.03%-7.89%-8.99%-6.79%
FCF Yield
-7.81%-5.79%-6.01%-8.41%-4.84%
Buyback Yield / Dilution
-19.30%-0.80%-18.35%-7.88%-
Total Shareholder Return
-19.30%-0.80%-18.35%-7.88%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).